Stock comparison
ELI LILLY & Co is 310.1x more valuable than AbCellera Biologics Inc. by market capitalization ($1.082 T vs $3.49 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 310.1x more valuable than AbCellera Biologics Inc. by market capitalization ($1.082 T vs $3.49 B).
Market value leader
LLY
ELI LILLY & Co is 310.1x more valuable than AbCellera Biologics Inc. by market capitalization ($1.082 T vs $3.49 B).
Revenue leader
LLY
ABCL: $75.13M vs LLY: $65.18B.
Profit leader
LLY
ABCL: -$146.41M vs LLY: $20.64B.
Margin leader
LLY
ABCL: -194.9% vs LLY: 31.7% net margin.
| Metric | ABCL | LLY |
|---|---|---|
| Market cap | $3.49 B | $1.082 T |
| US-listed rank | #1718 | #11 |
| Revenue (latest FY) | $75.13M | $65.18B |
| Net income (latest FY) | -$146.41M | $20.64B |
| Net margin | -194.9% | 31.7% |
| P/E (trailing FY) | - | 52.4x |
| SEC filings | 297 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 310.1x more valuable than AbCellera Biologics Inc. by market capitalization ($1.082 T vs $3.49 B).
In their latest fiscal years, AbCellera Biologics Inc. reported $75.13M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: AbCellera Biologics Inc. and ELI LILLY & Co, or browse the full rankings.